Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 10, 2022

BUY
$1.35 - $2.24 $8,128 - $13,487
6,021 Added 162.2%
9,733 $14,000
Q2 2022

Aug 15, 2022

BUY
$1.33 - $2.35 $4,936 - $8,723
3,712 New
3,712 $7,000
Q1 2022

May 12, 2022

SELL
$1.86 - $3.24 $5,890 - $10,261
-3,167 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$2.2 - $4.01 $5,205 - $9,487
-2,366 Reduced 42.76%
3,167 $7,000
Q3 2021

Nov 15, 2021

BUY
$3.34 - $4.63 $18,480 - $25,617
5,533 New
5,533 $18,000
Q2 2021

Aug 16, 2021

SELL
$3.38 - $5.71 $16,977 - $28,681
-5,023 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$3.77 - $6.05 $5,572 - $8,941
1,478 Added 41.69%
5,023 $27,000
Q4 2020

Feb 16, 2021

BUY
$3.12 - $4.08 $9,734 - $12,729
3,120 Added 734.12%
3,545 $13,000
Q3 2020

Nov 16, 2020

SELL
$3.09 - $4.14 $3,763 - $5,042
-1,218 Reduced 74.13%
425 $2,000
Q2 2020

Aug 13, 2020

BUY
$1.47 - $2.97 $221 - $448
151 Added 10.12%
1,643 $5,000
Q1 2020

May 15, 2020

SELL
$1.57 - $3.1 $11,737 - $23,175
-7,476 Reduced 83.36%
1,492 $2,000
Q4 2019

Feb 07, 2020

BUY
$2.72 - $3.15 $20,625 - $23,886
7,583 Added 547.51%
8,968 $28,000
Q3 2019

Nov 05, 2019

SELL
$2.58 - $3.97 $8,622 - $13,267
-3,342 Reduced 70.7%
1,385 $5,000
Q2 2019

Aug 13, 2019

BUY
$3.0 - $5.5 $10,611 - $19,453
3,537 Added 297.23%
4,727 $16,000
Q1 2019

May 14, 2019

BUY
$4.24 - $5.24 $1,102 - $1,362
260 Added 27.96%
1,190 $6,000
Q4 2018

Feb 14, 2019

SELL
$3.95 - $6.55 $4,238 - $7,028
-1,073 Reduced 53.57%
930 $4,000
Q3 2018

Nov 13, 2018

BUY
$6.1 - $7.1 $2,952 - $3,436
484 Added 31.86%
2,003 $13,000
Q2 2018

Aug 15, 2018

BUY
$5.05 - $7.35 $6,544 - $9,525
1,296 Added 581.17%
1,519 $11,000
Q1 2018

May 15, 2018

SELL
$3.9 - $5.5 $1,778 - $2,508
-456 Reduced 67.16%
223 $1,000
Q4 2017

Feb 09, 2018

BUY
$4.25 - $5.2 $854 - $1,045
201 Added 42.05%
679 $3,000
Q3 2017

Nov 14, 2017

BUY
$4.8 - $6.95 $2,294 - $3,322
478
478 $3,000

About MediWound Ltd.


  • Ticker MDWD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,735,200
  • Market Cap $798M
  • Description
  • MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel and bio-therapeutic solutions for tissue repair and regeneration. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hosp...
More about MDWD
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.